KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Pfizer (PFE) Shareholder's Equity (2009 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shareholder's Equity (Qtr)
1	Novartis Ag	107,124,802.25 Bn	107,124,802.25 Bn	-	-
2	Eli Lilly	969.00 Bn	963.72 Bn	16.22 Bn	31.20 Bn
3	Johnson & Johnson	539.46 Bn	517.41 Bn	15.96 Bn	81.19 Bn
4	AbbVie	376.92 Bn	367.57 Bn	10.78 Bn	-6.66 Bn
5	Merck	285.00 Bn	279.35 Bn	12.09 Bn	45.88 Bn
6	Amgen	177.58 Bn	165.55 Bn	5.87 Bn	9.19 Bn
7	Gilead Sciences	163.22 Bn	155.50 Bn	5.52 Bn	23.52 Bn
8	Pfizer	145.86 Bn	133.09 Bn	-1.21 Bn	90.10 Bn
9	Bristol Myers Squibb	111.90 Bn	101.44 Bn	8.07 Bn	20.07 Bn
10	Gsk	88.34 Bn	83.66 Bn	-	21.78 Bn

Historic Data

Download Data 🔒

Date	Value
Mar 29, 2026	90.10 Bn
Dec 31, 2025	86.48 Bn
Sep 28, 2025	93.10 Bn
Jun 29, 2025	89.01 Bn
Mar 30, 2025	90.64 Bn
Dec 31, 2024	88.50 Bn
Sep 29, 2024	92.56 Bn
Jun 30, 2024	87.98 Bn
Mar 31, 2024	92.56 Bn
Dec 31, 2023	89.29 Bn
Oct 1, 2023	97.20 Bn
Jul 2, 2023	99.29 Bn
Apr 2, 2023	101.24 Bn
Dec 31, 2022	95.92 Bn
Oct 2, 2022	92.89 Bn
Jul 3, 2022	87.47 Bn
Apr 3, 2022	82.69 Bn
Dec 31, 2021	77.46 Bn
Oct 3, 2021	35.98 Bn
Jul 4, 2021	70.32 Bn
Apr 4, 2021	68.87 Bn
Dec 31, 2020	63.47 Bn
Sep 27, 2020	34.15 Bn
Jun 28, 2020	64.57 Bn
Mar 29, 2020	65.34 Bn
Dec 31, 2019	63.45 Bn
Sep 29, 2019	35.30 Bn
Jun 30, 2019	59.92 Bn
Mar 31, 2019	59.16 Bn
Dec 31, 2018	63.76 Bn
Sep 30, 2018	71.66 Bn
Jul 1, 2018	70.12 Bn
Apr 1, 2018	70.54 Bn
Dec 31, 2017	71.66 Bn
Oct 1, 2017	61.11 Bn
Jul 2, 2017	58.69 Bn
Apr 2, 2017	58.44 Bn
Dec 31, 2016	59.84 Bn
Oct 2, 2016	63.60 Bn
Jul 3, 2016	62.77 Bn
Apr 3, 2016	63.35 Bn
Dec 31, 2015	65.00 Bn
Sep 27, 2015	66.84 Bn
Jun 28, 2015	66.89 Bn
Mar 29, 2015	67.59 Bn
Dec 31, 2014	71.62 Bn
Sep 28, 2014	78.31 Bn
Jun 29, 2014	76.96 Bn
Mar 30, 2014	77.77 Bn
Dec 31, 2013	76.62 Bn
Sep 29, 2013	78.35 Bn
Jun 30, 2013	78.55 Bn
Mar 31, 2013	82.25 Bn
Dec 31, 2012	81.68 Bn
Sep 30, 2012	81.70 Bn
Jul 1, 2012	79.55 Bn
Apr 1, 2012	83.26 Bn
Dec 31, 2011	82.62 Bn
Oct 2, 2011	90.05 Bn
Jul 3, 2011	88.48 Bn
Apr 3, 2011	90.07 Bn
Dec 31, 2010	88.27 Bn
Oct 3, 2010	87.64 Bn
Jul 4, 2010	86.44 Bn
Apr 4, 2010	90.08 Bn
Dec 31, 2009	90.45 Bn
Sep 27, 2009	66.16 Bn
Jun 28, 2009	63.04 Bn